192 related articles for article (PubMed ID: 24928451)
1. High estrogen in men after injectable testosterone therapy: the low T experience.
Tan RS; Cook KR; Reilly WG
Am J Mens Health; 2015 May; 9(3):229-34. PubMed ID: 24928451
[TBL] [Abstract][Full Text] [Related]
2. Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.
Rhoden EL; Morgentaler A
Int J Impot Res; 2004 Feb; 16(1):95-7. PubMed ID: 14963480
[TBL] [Abstract][Full Text] [Related]
3. EAA clinical practice guidelines-gynecomastia evaluation and management.
Kanakis GA; Nordkap L; Bang AK; Calogero AE; Bártfai G; Corona G; Forti G; Toppari J; Goulis DG; Jørgensen N
Andrology; 2019 Nov; 7(6):778-793. PubMed ID: 31099174
[TBL] [Abstract][Full Text] [Related]
4. Andropause: is androgen replacement therapy indicated for the aging male?
Hijazi RA; Cunningham GR
Annu Rev Med; 2005; 56():117-37. PubMed ID: 15660505
[TBL] [Abstract][Full Text] [Related]
5. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
Leder BZ; Rohrer JL; Rubin SD; Gallo J; Longcope C
J Clin Endocrinol Metab; 2004 Mar; 89(3):1174-80. PubMed ID: 15001605
[TBL] [Abstract][Full Text] [Related]
6. Testosterone replacement in elderly men.
Baum NH; Crespi CA
Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
[TBL] [Abstract][Full Text] [Related]
7. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism.
Herzog AG; Farina EL; Drislane FW; Schomer DL; Smithson SD; Fowler KM; Dworetzky BA; Bromfield EB
Epilepsy Behav; 2010 Feb; 17(2):264-71. PubMed ID: 20096638
[TBL] [Abstract][Full Text] [Related]
8. Alternatives to Testosterone Therapy: A Review.
Lo EM; Rodriguez KM; Pastuszak AW; Khera M
Sex Med Rev; 2018 Jan; 6(1):106-113. PubMed ID: 29174957
[TBL] [Abstract][Full Text] [Related]
9. Estrogens in men: clinical implications for sexual function and the treatment of testosterone deficiency.
Kacker R; Traish AM; Morgentaler A
J Sex Med; 2012 Jun; 9(6):1681-96. PubMed ID: 22512993
[TBL] [Abstract][Full Text] [Related]
10. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy.
Ramasamy R; Scovell JM; Kovac JR; Lipshultz LI
J Urol; 2014 Sep; 192(3):875-9. PubMed ID: 24657837
[TBL] [Abstract][Full Text] [Related]
11. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization.
Spratt DI; Morton JR; Kramer RS; Mayo SW; Longcope C; Vary CP
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E631-8. PubMed ID: 16670151
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Non-Testosterone-Based Treatment in Hypogonadal Men: A Review.
Raheem OA; Chen T; Akula KP; Greenberg J; Le TV; Chernobylsky D; Sikka SC; Walsh TJ
Sex Med Rev; 2021 Jul; 9(3):381-392. PubMed ID: 33933392
[TBL] [Abstract][Full Text] [Related]
13. Conversion of androgens to estrogens in idiopathic hemochromatosis: comparison with alcoholic liver cirrhosis.
Kley HK; Niederau C; Stremmel W; Lax R; Strohmeyer G; Krüskemper HL
J Clin Endocrinol Metab; 1985 Jul; 61(1):1-6. PubMed ID: 3998072
[TBL] [Abstract][Full Text] [Related]
14. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism.
Shabsigh A; Kang Y; Shabsign R; Gonzalez M; Liberson G; Fisch H; Goluboff E
J Sex Med; 2005 Sep; 2(5):716-21. PubMed ID: 16422830
[TBL] [Abstract][Full Text] [Related]
15. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.
Lee H; Finkelstein JS; Miller M; Comeaux SJ; Cohen RI; Leder BZ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1069-75. PubMed ID: 16352679
[TBL] [Abstract][Full Text] [Related]
17. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
[TBL] [Abstract][Full Text] [Related]
18. Testosterone therapy in men.
Theodoraki A; Bouloux PM
Menopause Int; 2009 Jun; 15(2):87-92. PubMed ID: 19465676
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.
Salehian B; Wang C; Alexander G; Davidson T; McDonald V; Berman N; Dudley RE; Ziel F; Swerdloff RS
J Clin Endocrinol Metab; 1995 Dec; 80(12):3567-75. PubMed ID: 8530600
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets.
Pastuszak AW; Mittakanti H; Liu JS; Gomez L; Lipshultz LI; Khera M
J Androl; 2012; 33(5):927-37. PubMed ID: 22403285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
